This renewal application will deepen and extend our understanding of the effects of syringe exchange programs (SEP) by examining the phenomenon of secondary syringe exchange. Secondary syringe exchange (SSE) is the provision of syringes obtained from SEPs by injection drug users (IDUs) to other IDUs who do not attend SEPs. In addition, we will conduct and evaluate a peer mobilization intervention based on SSE networks. This research builds upon nine years of ongoing research with IDUs in the communities of Oakland and Richmond, CA (NIDA grants U01-DA06908 and R01-DA09532). Our studies have demonstrated the dramatic impact of SEPs on reducing the prevalence of high-risk injection practices. However, we have also found that many IDUs do not directly access SEPs, but rather obtain syringes from other IDUs who use SEPs. This practice is increasing among IDUs and extends the reach of SEPs, allowing sterile syringes to be distributed to many more IDUs than those who attend the programs. However, our data suggest that IDUs who receive syringes indirectly from SEPs through SSE were more likely to engage in high-risk injection practices than those who use SEPs directly and even those who do not use SEPs at all. The purpose of this grant is to better understand SSE practices and relationships, and to build upon these naturally occurring social networks with a peer mobilization intervention.
The specific aims are as follows: (1) To investigate the prevalence, motivations and social contexts of secondary exchange relationships through a mixture of qualitative and quantitative research methods; (2) To prospectively assess levels of injection risk behaviors and HIV and HCV infection among IDUs engaging in secondary exchange relationships of different kinds; and (3) To develop, implement, and evaluate a social network-based peer mobilization intervention aimed at engaging secondary syringe exchange providers as peer educators and training them to provide education, motivation, and support for risk reduction among their secondary syringe exchange recipients.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA009532-06
Application #
6515537
Study Section
Special Emphasis Panel (ZRG1-AARR-7 (01))
Program Officer
Hartsock, Peter
Project Start
1995-07-15
Project End
2003-03-31
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
6
Fiscal Year
2002
Total Cost
$627,304
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
O'Brien, Thomas R; Pfeiffer, Ruth M; Paquin, Ashley et al. (2015) Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. J Hepatol 63:1103-10
Prokunina-Olsson, Ludmila; Muchmore, Brian; Tang, Wei et al. (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45:164-71
Uccellini, Lorenzo; Tseng, Fan-Chen; Monaco, Alessandro et al. (2012) HCV RNA levels in a multiethnic cohort of injection drug users: human genetic, viral and demographic associations. Hepatology 56:86-94
Shebl, Fatma M; Pfeiffer, Ruth M; Buckett, Dianna et al. (2011) IL28B rs12979860 genotype and spontaneous clearance of hepatitis C virus in a multi-ethnic cohort of injection drug users: evidence for a supra-additive association. J Infect Dis 204:1843-7
Dias, Paulo Telles; Hahn, Judith A; Delwart, Eric et al. (2011) Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California. BMC Infect Dis 11:208
Edlin, Brian R; Shu, Marla A; Winkelstein, Emily et al. (2009) More rare birds, and the occasional swan. Gastroenterology 136:2412-4
Mizukoshi, Eishiro; Eisenbach, Christoph; Edlin, Brian R et al. (2008) Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV. J Infect Dis 198:203-12
Page-Shafer, Kimberly; Pappalardo, Brandee L; Tobler, Leslie H et al. (2008) Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol 46:499-506
Brown, Elizabeth E; Zhang, Mingdong; Zarin-Pass, Rebecca et al. (2008) MBL2 and hepatitis C virus infection among injection drug users. BMC Infect Dis 8:57
Tseng, F-C; Edlin, B R; Zhang, M et al. (2008) The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use. J Viral Hepat 15:690-8

Showing the most recent 10 out of 28 publications